Archive for May, 2008
Society Of Urologic Oncology Meeting - Repeat Prostate Biopsy - When, Where And How?
ORLANDO, FL (UroToday.com) - Dr. Presti discussed that the adequacy of the initial biopsy must be assessed. One must examine how many cores were taken on the first biopsy. whether it was only 6 cores, there was a 40% chance of finding cancer on the second biopsy as compared to 24% when an extended p…
Society Of Urologic Oncology Meeting - Renal Carcinoma - Management Of The Small Renal Mass - Minimally Invasive Treatment
ORLANDO, FL (UroToday.com) - Dr. Peter Pinto discussed ablative therapies and evolving treatments for the small renal mass. He addressed laparoscopic partial nephrectomy. The learning curve is steep and requires technical expertise. However, at centers of excellence it is a good technique. whether t…
Society Of Urologic Oncology Meeting - Renal Carcinoma - Management Of The Small Renal Mass - Evolving Role Of Needle Biopsy In 2008 And Beyond
ORLANDO, FL (UroToday.com) - Dr. David Wood discussed the role of renal mass biopsy. He presented a case of a 65 year old man with metastatic prostate cancer as compared to a 65 year old man with a 2.7cm exophytic solid renal mass. The likelihood of renal cancer is 72% in that setting. Yet most woul…
Society Of Urologic Oncology Meeting - Renal Carcinoma - Management Of The Small Renal Mass - Observation Not Treatment
ORLANDO, FL (UroToday.com) - Dr. Robert Uzzo argued for observation in many renal masses. Despite the fact that kidney cancer is a deadly disease, it is additionally heterogeneous. Despite the fact that kidney cancer is a deadly disease, it is plus heterogeneous. He performed a meta-analysis to comp…
Society Of Urologic Oncology Meeting - Prostate Cancer II
ORLANDO, FL (UroToday.com) - Dr. Howard Sandler argued for an integrated approach to prostate cancer beginning with radiotherapy (XRT). He described locally advanced CaP as cT3b disease with high Gleason score and PSA. One can’t ask more of local control and thus a multimodal treatment plan is…
Society Of Urologic Oncology Meeting - Optimizing BCG Therapy In 2008
ORLANDO, FL (UroToday.com) - Dr. O’Donnell argued for optimizing BCG therapy in patients failing an initial round of intravesical therapy. For low risk patients, there is small risk of disease progression and thus treatment is not needed. Selection of the best candidates has the highest respon…
AUA 2008 - Society Of Urologic Oncology Meeting - Intravesical Chemotherapy Deserves A Chance
ORLANDO, FL (UroToday.com) - Professor Witjes pointed out that bladder cancer incidence is much higher in Europe than in the US. He reviewed the AUA guidelines for T1G3 TCC. BCG with maintenance should be given and cystectomy should be considered an option. that is similar to the EAU guidelines. The…
